SCHEMBL23305171

SCHEMBL23305171

C[C@H]1C[C@]2(Cc3cc(O)ncc3O2)CN1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23304715 0.88 IRAK4 (0.32) —
SCHEMBL23304778 0.87 CCNC (0.30) —
SCHEMBL30200940 0.87 CCNC (0.30) —
SCHEMBL23305305 0.85 — —
SCHEMBL23304876 0.85 HPGDS (0.32) —
SCHEMBL23305557 0.85 ACACB (0.34) —
SCHEMBL23317063 0.85 ACACB (0.34) —
SCHEMBL31059155 0.85 ACACB (0.34) —
SCHEMBL23304675 0.84 HCAR3 (0.36) —
SCHEMBL23304822 0.84 IRAK4 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230060003-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. 2023-02-23 — — US disclosed
WO-2021086966-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. (US) 2021-05-06 — — WO disclosed
Send feedback